Nordicus Partners Corporation disclosed on October 21, 2026, that it entered into a promissory note agreement on October 15, 2026. The company issued the note to ABCHill Holding ApS for a principal amount of $147,000.
The note is payable on demand and carries an interest rate equal to the lesser of 6.0% per annum or the maximum rate permitted by applicable law. Interest is calculated based on a 365-day year and actual days elapsed.
The lender, ABCHill Holding ApS, is wholly owned and controlled by Christian Hill-Madsen. Mr. Hill-Madsen serves as a Director of the company's subsidiaries Orocidin A/S and Bio-Convert A/S, as CEO of NP Bioinnovation A/S, and as COO of NoviThera ApS.
The note was issued pursuant to an exemption from registration under Section 4(a)(2) of the Securities Act of 1933, as a transaction not involving a public offering. The company noted that the lender had access to information concerning the company and acquired the note for investment purposes.
Under the terms of the agreement, the outstanding principal balance and accrued interest are due and payable on demand. In the event of default, including nonpayment or certain insolvency events, the lender may declare all amounts immediately due and payable. The company may prepay the note, in whole or in part, at any time without premium or penalty.
A copy of the promissory note is filed as Exhibit 10.1 to the current report on Form 8-K.
